Modafinil Leads to Significant Improvement in Some Subtypes of ADHD

New research provides evidence that Modafinil can greatly improve symptoms in children with inattentive or combined type ADHD.

Wednesday February 20th - 10:58am

Researchers at Massachusetts General Hospital in Boston have found evidence supporting the use of Modafinil in the treatment of children with inattentive type or combined types ADHD. Modafinil, marketed under the brand name Provigil, is a psychostimulant that may cause less anxiety, excessive motor activity, and "jitteriness" than traditional stimulants.

The current research used 3 double-blind placebo studies, meaning that in each study neither the participants themselves nor those treating them knew whether they were taking the medication or a placebo. The study participants included children aged six- to 17-years-old and included children diagnosed with each of the three subtypes of ADHD.

Questionnaires to measure the functioning of each child were administered to parents, teachers, and clinicians after 7 to 9 weeks. Children with inattentive or combined types of ADHD showed significant improvements in symptoms and functioning both at home and school, providing evidence that Modafinil may be an effective treatment for children with these subtypes.

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018